Catalog

Sri Lanka National Immunization Program Financing Assessment

E-mail or fax the Publications Unit at + 632 636 2648 to order the printed version of this publication. Applicable shipping cost will be charged. View Document  Books, Periodicals, Studies, and Reports On-line edition: Free of Charge Hardcopy price: $10.00 ISBN: 971-561-348-9 Paperback (Pub. Date: 2001) In stock

Since its independence, the Government of Sri Lanka has made it a priority to develop an equitable health-care system with a focus on primary health care. As a result, health indicators are excellent, particularly relative to comparable low- or lower-middle-income countries. Immunization has been an integrated component of the primary health care program for 20 years.

Through this assessment of financing issues in the national immunization program of Sri Lanka and a review of existing documentation, this paper seeks to identify the following:

• the financial status of the program including financing gaps
• future funding requirements for a routine (or expanded) program
• sustainable financial options for strengthening the program
• anticipated and potential funding sources

47 pages.

RELATED DOCUMENTS

Immunization Financing in Developing Countries and International Vaccine Market Azerbaijan National Immunization Program Financing Assessment Kazakhstan and Kyrgyz Republic National Immunization Program Financing Assessment Mongolia National Immunization Program Financing Assessment Uzbekistan National Immunization Program Financing Assessment

View the document [ PDF: 277kb | 54 pages ]. To read, you need Acrobat.

Contents

---

Executive Summary

Introduction

Purpose

Methodology

Background

Socioeconomic Situation

Health resource allocation

Demographic and Health Indicators

Vaccine-preventable diseases

Health System

Structure and decentralization
Finance
Donor support

National Immunization Program

Strategic Plan

Organizational Structure

Coverage

Financial Structure

Government sources: National level
Government sources: Provincial level

Past and Current Financing

Vaccine costs
Nonvaccine costs
Overall

Future Financing

Key Issues

Vaccine supply: Sustainability, quality assurance, and price

Quality assurance
Costs and financing
Laboratory services and surveillance

Vaccine management and the cold chain

Wastage rates
Forecasting
Storage
Transport
Equipment
Maintenance
Costs and financing

Quality and community commitment

Supervision
Environment
Costs and financing

Equitable access

Estate sector
Conflict zones in the north and east
Costs and financing

Safety of injections

Costs and financing

Introduction of new vaccines

Hepatitis B
Costs and financing
Haemophilus influenzae type B (Hib)

Disease control initiatives

Polio
Measles
Costs and financing
Neonatal tetanus

Financing Needs, Sources, and Gaps

Projected costs: Basic EPI program
Projected costs: Strengthened/expanded program
Projected Sources and Funding Gap

Policy and Financing Options

Policy Options

Vaccine management
Donor dependence
Cold-chain equipment: Management and procurement
Monitoring

Financing Options

Vaccines
Vaccine management and the cold chain
Quality and community commitment
Equitable access
Injection safety
Introduction of new vaccines
Disease control strategies
Summary

Recommendations